Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$24.99

Common-Size Income Statement
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Bristol-Myers Squibb Co., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net product sales
Alliance and other revenues
Revenues
Cost of products sold, excludes amortization of acquired intangible assets
Gross margin
Marketing, selling and administrative
Research and development
Acquired IPRD
Amortization of acquired intangible assets
Operating income (loss)
Other income (expense), net
Earnings (loss) before income taxes
Income tax (provision) benefit
Net earnings (loss)
Noncontrolling interest
Net earnings (loss) attributable to BMS

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Revenue Composition
Net product sales consistently represent the majority of revenues, typically around 96-97.7%. Alliance and other revenues generally account for the remaining 2-4%, with fluctuations observed, notably peaking at 4.3% in mid-2024 and dipping below 2.3% in early 2025. Overall, the revenue structure remains stable with net product sales as the primary contributor.
Cost of Products Sold and Gross Margin
The cost of products sold as a percentage of revenues shows volatility, fluctuating between approximately -19.7% and -39%, with an unusual spike to nearly -39% in early 2025. Most quarters maintain costs around -20% to -26%. Correspondingly, gross margin peaks around 80.3% in late 2021 and dips to a low near 61% in early 2025. This suggests a generally strong gross margin, interrupted by occasional cost spikes impacting profitability.
Operating Expenses
Marketing, selling, and administrative expenses generally range from about -14% to -20% of revenues, with a slight upward trend during certain periods but no extreme changes. Research and development expenses typically fluctuate between -19% and -26%, displaying some volatility. An exception is seen in late 2020 when R&D expenses approach -34%, coinciding with a large acquired in-process research and development (IPRD) cost.
Acquired IPRD and Amortization
Acquired IPRD displays significant irregularities, including substantial negative values in late 2020 and mid-2024. These large spikes suggest notable acquisition-related expenses during these periods. The amortization of acquired intangible assets remains relatively stable between roughly -7% and -23%, with a downward trend starting in 2024, reaching as low as -7.4% towards the end of the data.
Operating Income and Profitability
Operating income fluctuates considerably, with strong positive results generally between 7.97% and 20.79% of revenues in most quarters. However, unusually large losses occur in late 2020 (-110.92%) and early 2024 (-96.38%), corresponding to periods with major acquired IPRD charges. Other quarters maintain moderate to strong operating profitability.
Other Income (Expense), Net
Other income and expense figures are somewhat volatile but generally small relative to revenues, ranging between approximately -10.8% and +16.5%. The item shows negative impact during some quarters in 2022-2025 but remains relatively minor compared to operating income swings.
Earnings Before Income Taxes and Net Earnings
Earnings before income taxes mirror the pattern of operating income, with mostly positive values varying from around 10% to 26%, in line with operational performance. Extreme negative values recorded in late 2020 and early 2024 persist here, reflecting significant non-recurring losses. Net earnings attributable to the company follow the same trend, with notable losses in these exceptional quarters but otherwise maintaining positive earnings typically in the range of 10-20%.
Income Tax Provision
Income tax provision exhibits high variability, with some quarters showing tax benefits (positive percentages) and others showing provisions. This volatility likely reflects the impact of fluctuating earnings and unusual items on taxable income. There is no clear directional trend.